Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Core EBITDA

    Back to All Ratios
ORCHID PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 13.506.4636.4218.0322.34

What is the latest EV/Core EBITDA ratio of ORCHID PHARMA ?

The latest EV/Core EBITDA ratio of ORCHID PHARMA is 13.50 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202613.50
Mar20256.46
Mar202436.42
Mar202318.03
Mar202222.34

How is EV/Core EBITDA of ORCHID PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2026 13.5
108.98
Mar2025 6.46
-82.26
Mar2024 36.42
102.00
Mar2023 18.03
-19.29
Mar2022 22.34 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Core EBITDA ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹6,610.9 Cr 15.4% 6.3% 55.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,476.0 Cr -0.1% -2.4% 13.8% Stock Analytics
DIVIS LABORATORIES ₹254,764.0 Cr 2.7% 12.9% 54.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,423.0 Cr 1.8% 2.5% 40.9% Stock Analytics
CIPLA ₹111,484.0 Cr 0.6% -3.8% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,005.0 Cr 3.3% 1.3% -7.6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

15.4%

6.3%

55.3%

SENSEX

0.7%

-3.5%

-9.2%


You may also like the below Video Courses